The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neoadjuvant accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) in patients with high-grade upper-tract urothelial carcinoma.
Jean H. Hoffman-Censits
No relevant relationships to disclose
Edouard John Trabulsi
No relevant relationships to disclose
David Y. T. Chen
No relevant relationships to disclose
Alexander Kutikov
No relevant relationships to disclose
Jianqing Lin
No relevant relationships to disclose
Rosalia Viterbo
No relevant relationships to disclose
Gary R. Hudes
No relevant relationships to disclose
Kelly A. Healy
No relevant relationships to disclose
Scott Hubosky
No relevant relationships to disclose
Yu-Ning Wong
No relevant relationships to disclose
Deborah Kilpatrick
No relevant relationships to disclose
Beth Adair
No relevant relationships to disclose
Charlotte Cione
No relevant relationships to disclose
Elizabeth R. Plimack
No relevant relationships to disclose